oral tirzepatide clinical trial for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled Tirzepatide on ingestive behavior in

Oral semaglutide versus subcutaneous semaglutide and placebo in type 2 diabetes: A 52-week randomized, open-label, phase 3a trial

Depression, binge eating disorder, and other psychiatric diagnoses are more prevalent in individuals with obesity and may independently impair treatment adherence and lifestyle modification

Regular follow-up with healthcare providers ensures that menstrual changes are monitored appropriately, underlying conditions are managed, and treatment with Mounjaro continues to provide metabolic benefits whilst minimising adverse effects on reproductive health

When removed, baseline appetite and reward signalling reasserts itself

Frequently asked questions Is compounded semaglutide with B12 the same as Ozempic

Medications such as semaglutide, liraglutide, and tirzepatide are altering the landscape of weight loss and health management